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Abstract
Background: Studies relating long-term exposure to persistent organochlorine pollutants (POPs) with endocrine activities
(endocrine disrupting chemicals) on circulating levels of steroid hormones have been limited to a small number of
hormones and reported conflicting results.
Objective: We examined the relationship between serum concentrations of dehydroepiandrosterone, dehydroepiandros-
terone sulphate, androstenedione, androstenediol, testosterone, free and bioavailable testosterone, dihydrotestosterone,
estrone, estrone sulphate, estradiol, sex-hormone binding globulin, follicle-stimulating hormone, and luteinizing hormone
as a function of level of exposure to three POPs known to interfere with hormone-regulated processes in different way:
dichlorodiphenyl dichloroethene (DDE), polychlorinated biphenyl (PCB) congener 153, and chlordecone.
Methods: We collected fasting, morning serum samples from 277 healthy, non obese, middle-aged men from the French
West Indies. Steroid hormones were determined by gas chromatography-mass spectrometry, except for dehydroepian-
drosterone sulphate, which was determined by immunological assay, as were the concentrations of sex-hormone binding
globulin, follicle-stimulating hormone and luteinizing hormone. Associations were assessed by multiple linear regression
analysis, controlling for confounding factors, in a backward elimination procedure, in multiple bootstrap samples.
Results: DDE exposure was negatively associated to dihydrotestosterone level and positively associated to luteinizing
hormone level. PCB 153 was positively associated to androstenedione and estrone levels. No association was found for
chlordecone.
Conclusions: These results suggested that the endocrine response pattern, estimated by determining blood levels of
steroid hormones, varies depending on the POPs studied, possibly reflecting differences in the modes of action generally
attributed to these compounds. It remains to be investigated whether this response pattern is predictive of the subsequent
occurrence of disease.
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Introduction
An endocrine-disrupting chemical (EDC) is an exogenous
chemical that can interfere with various aspects of hormone
function, synthesis, secretion, regulation, action and elimination
[1,2]. EDCs may thus have deleterious effects on many endocrine
system and outcomes in both humans and wildlife [3]. There is
growing evidence that adverse reproductive outcomes, including
reproductive organ tumors, may result from exposure to EDCs
present at low concentrations in the environment, although
epidemiological evidence of a causal relationship remains limited
[4].
Various EDCs exert their effects through steroid-mediated
pathways, by interfering with the binding of physiological ligands
to steroid receptors and binding proteins and enzymes involved in
the steroid biosynthesis pathway [5]. The synthesis and secretion
of steroid hormones are controlled by positive and negative
feedback mechanisms, but it has been suggested that exposure to
EDCs may also result in slight, but real modifications of circulating
steroid hormone levels.
Several studies have investigated relationships between persis-
tent organochlorine pollutants (POPs) with endocrine properties
and a limited number of steroid hormones, mostly testosterone (T)
and estradiol (E2), in blood samples from populations of adult
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men. These studies have focused mostly on ubiquitous environ-
mental pollutants, such as dichlorodiphenyl dichloroethene (DDE,
the major and most stable metabolite of dichlorodiphenyl
trichloroethane, DDT) and polychlorinated biphenyls (PCBs) [6–
22]. No significant effect was found in most of these studies, but
the overall picture is not uniform. There are several possible
reasons for these discrepancies and for the lack of comparability
between studies: differences in the age range investigated or in the
exposure levels experienced by the populations, lack of controls for
some potentially confounding factors and the use of different
immunological hormone assay methods with different perfor-
mances.
We investigated the possible effects of long-term exposure to
various POPs on blood levels of steroid hormones, binding
proteins and gonadotrophins in healthy, non obese, middle-aged
French West Indian men. We focused on DDE, PCBs and
chlordecone. These chemicals are known to bind to androgen
(AR) and/or estrogen (ER) steroid receptors and to interfere with
hormone-regulated processes in different ways [23–25]. The
effects of these compounds on blood steroid levels may be
mediated by effects on any of the components of the steroid
pathway. We therefore investigated a wide panel of blood
androgens and estrogens, determining the levels of these
compounds mostly by gas chromatography-mass spectrometry
(GC–MS), the gold standard method for steroid hormone assay
[26,27]. Given the interconnection between steroid production by
the testis and hypophyseal hormones, we also determined
circulating follicle-stimulating hormone (FSH) and luteinizing
hormone levels (LH).
Materials and Methods
Ethics Statement
The study was approved by the Guadeloupe Ethics Committee
for studies involving human subjects. Each participant provided
written informed consent.
Study Population
This study took place in Guadeloupe (French West Indies), a
Caribbean archipelago, most of the inhabitants of which are of
African descent. Subjects were recruited from men participating in
a free yearly systematic health-screening program funded by the
French national health insurance system. Each year, a random
sample of the population, selected so as to be representative of the
age and sex distribution of the general population, is invited to
participate in the program at a single site. As part of the
Karuprostate prostate cancer study, consecutively enlisted men
aged 45 to 69 years of age were invited to participate [28]. The
acceptance rate was around 90%. Information was obtained from
participants about their demographic characteristics, anthropo-
metric measurements, lifestyle, medical records and medication
use. The inclusion criteria for this study were: a) both parents born
on any Caribbean island with a population of predominantly
African descent, b) no history of a chronic medical disorder and
standard biochemical and hematological blood parameters in the
normal range, c) no hormone treatments or drugs known to
influence the hypothalamic-pituitary-gonadal-adrenal axis (includ-
ing inhibitors of 5 a reductase), d) body mass index (BMI),30. A
blood sample was drawn from each participant between 8.00 and
10.00 a.m., after overnight fasting. Serum samples were separated
and frozen at 230u until shipment. Samples were identified only
by a unique sample code and were transferred by airmail, on dry
ice, to Creteil (France) for hormone analysis and to Liege
(Belgium) for organochlorine and lipid analysis. All laboratory
personnel were blind to the identities of subjects.
Given the high cost of the analytical methods used, we limited
the initial sample size to 300 individuals, which, for a statistical
power of 0.8 and a p level of 0.05 gave an anticipated minimum
effect size (f2) of 0.05 for multiple regression studies with eight
predictors, not including the regression constant. We randomly
selected 60 individuals for each five-year age group, from the age
of 45 to 69 years. We excluded the men who did not fulfill the
inclusion criteria or who had provided too little blood to carry out
all the hormonal and chemical assays, resulting in a final sample
size of 277 subjects.
Measurement of hormones
Dehydroepiandrosterone (DHEA), androstenedione (AD), an-
drostenediol (ADIOL), total testosterone (T), dihydrotestosterone
(DHT), estrone (E1), E2, and estrone sulfate (E1S) were assayed
simultaneously by GC-MS, as previously described [29]. Briefly,
deuterated steroid internal standards (CDN Isotopes, Inc., Point-
Claire, Quebec, Canada) were added to all serum samples, which
were then extracted with 1-chlorobutane. The organic extracts
were purified on conditioned high-purity silica LC-Si SPE
columns (Varian, Les Ulis, France). All steroids were derivatized
with pentafluorobenzoyl chloride, except for AD, which was
derivatized with pentafluorobenzylhydroxylamine. The final
extracts were reconstituted in isooctane, then transferred to
conical vials for injection into the GC system (6890N, Agilent
Technologies, Massy, France), equipped with a 50% phenyl-
methylpolysiloxane VF-17MS capillary column (20 m60.15 mm,
internal diameter, 0.15 mm film thickness; Varian). An HP5973
(Agilent Technologies) quadrupole mass spectrometer equipped
with a chemical ionization source and operating in single-ion
monitoring mode was used for detection. E1S was determined as
E1 after acid solvolysis [30]. Free T (fT) concentrations were
calculated from T and SHBG concentrations, as previously
described [31]. Bioavailable T (BT) concentration was determined
as described elsewhere [29,31]. DHEAS was determined by a
radioimmunological method (IM 0729, Beckman Coulter, Mar-
seilles, France). Plasma SHBG, FSH and LH levels were
determined by radioimmunometric methods (using the following
kits: Schering SHBG RIACT, Gif-sur-Yvette, France; FSH kit and
LH kit, Coulter Immunotech, Marseilles, France). The molecular
masses of the derivatized steroids (deuterated and corresponding
non deuterated steroids), as assayed by GC–MS, and the means
and intra- and inter-assay coefficients of variation of four quality
control sera (one with very low concentrations of the assayed
steroids for determination of the lower limit of quantification by
GC-MS, and three with higher concentration levels) are reported
in Supporting Information File S1 (Table S1). The results of BT,
DHEAS, SHBG, FSH and LH quality controls are also reported
in Table S1.
Measurement of organochlorines
A high-resolution gas chromatograph (Thermo Quest Trace
2000, Milan, Italy) equipped with a Ni63 electron capture
detection system was used to assess the serum concentrations of
seven indicator PCB congeners (28, 52, 101, 118, 138, 153, and
180); p,p9-DDT, p,p9-dichlorodiphenyl dichloroethane (DDD) and
p,p9-DDE; the a, b, and c isomers of hexachlorocyclohexane
(HCH) and chlordecone. The limits of detection (LD) were
0.05 mg/l for all organochlorine compounds except chlordecone
(0.06 mg/l). Detailed information about sampling, analysis and
quality assurance and control have been provided elsewhere
[28,32]. Plasma total cholesterol and total triglyceride concentra-
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tions were determined enzymatically (DiaSys Diagnostic Systems
GmbH; Holzheim, Germany) and total lipid concentration was
calculated as previously described [33].
Data and statistical analysis
Continuous measurements were described in terms of the
median, range, mean and percentiles. We restricted our analysis to
pollutants with a detection frequency greater than 80%: DDE
(97%), PCB congeners 138 (96%), 153 (98%) and 180 (97%) and
chlordecone (87%). Values below the LD were estimated by a
maximum likelihood estimation method [34]. Correlations
between the concentrations of frequently detected pollutants were
explored by Spearman’s rank correlation analysis (Supporting
Information File S1, Table S2). The concentrations of the various
PCBs were highly correlated, so we restricted further analysis to
PCB 153.
The effects of exposure variables on the outcome variables were
evaluated by linear regression analyses. Scatter plots were used for
bivariate comparisons between exposure and outcome variables,
to ensure that linear associations were reasonable. Model
assumptions were checked by residual analysis. A normal
distribution of the residuals was achieved by natural log
transformations of outcomes and hormone ratios (DHEA,
DHEAS, T, AD, E2, E1, E1S, LH, FSH, and T/E2) or by
square root transformations (ADIOL, fT, BT, SHBG, and T/LH).
The exposure variables were treated as continuous variables and
were subjected to natural log transformation. The regression
coefficient (b) represented the change of naturally-log or square
root transformed outcomes variables per one unit of naturally-log
transformed serum organochlorine concentration The following
covariates were considered as potential confounding factors: age
(years, as a continuous variable), body mass index (BMI) (kg/m2),
waist-to-hip ratio (continuous), alcohol (current or past alcohol use
vs never) and tobacco consumption (current or past smoking vs
never), education (elementary/middle/high school), season of
blood collection (spring, summer, autumn, winter) and total lipid
concentration (mg/dl). For each exposure predictor, we also
considered the other contaminants as potential confounders. A
parsimonious and stable regression model was obtained, by the use
of a data-dependent procedure based on backward variable
elimination (PROC GLMSELECT) in multiple bootstrap samples
[35,36]. Variables were retained if they were selected in at least
30% of the 1000 bootstrap samples with a= 0.05. All analyses
were carried out with SAS software version 9.3 (SAS Institute,
Inc., Cary, NC, USA). All tests were two-tailed, and p values#0.05
were considered statistically significant.
Results
The participants were Caribbean men of African descent aged
between 45 and 69 years (median: 58 years). Overall, 61% had
never smoked and 15% were teetotal. The characteristics of the
study population with respect to potential confounders and
outcome variables are given in Table 1. Detection and concen-
trations of POPs in the serum samples of the study population are
presented in Table 2
The results of linear regression analysis for continuous exposure
variables are given in Table 3 for DDE, Table 4 for PCB 153, and
Table 5 for chlordecone. For each exposure, we present a crude
nonadjusted model and a backward adjusted model coupled to
bootstrap selection covariates.
We found a significant negative relationship between DDE and
DHT concentration in both crude and adjusted models
(b=20.063, 95% confidence interval (CI) =20.109 to 20.016,
p = 0.008) and a positive relationship between DDE and LH in
both crude (b= 0.053, CI = 0.001 to 0.106, p = 0.04) and adjusted
(b= 0.057, CI = 0.005 to 0.109; p = 0.03) models (Table 3). T/LH
ratio was negatively associated with DDE concentration in both
crude (b=20.066, CI =20.118 to 20.013, p = 0.01) and adjusted
(b=20.061, CI =20.112 to 20.010, p = 0.02) models.
PCB 153 concentration was positively associated to AD
concentration at the limit of significance in the crude model
(b= 0.045, CI = 0.0002 to 0.090, p = 0.05), and this relationship
was significant in the adjusted model (b= 0.054, CI = 0.010 to
0.098, p = 0.02). PCB 153 concentration was also significantly and
positively associated with E1 levels in the crude (b= 0.047,
CI = 0.004 to 0.090, p = 0.03) and adjusted (b= 0.048, CI = 0.005
to 0.092, p = 0.03) models (Table 4).
No association was observed between chlordecone and any
outcome in either the crude or the adjusted model (Table 5).
Discussion
We investigated associations between POPs with endocrine
activities and the levels of a large panel of hormones involved
primarily in the steroid pathway, in middle-aged French West
Indian men.
As expected and found in most populations worldwide, DDE
and PCB congeners 138, 153 and 180 were the most prevalent
POPs found in the blood in our population. Moreover, blood
concentrations of these pollutants are in the range of background
environmental levels currently found in US populations of similar
age range [37]. This is not surprising because the French West
Indies has and has had only very limited industrial activities
involving significant use or emission of PCBs. The use of DDT in
agricultural supplies or for disease vector control was anecdotic.
Consequently, exposure to these chemicals is likely to be associated
with background contamination of the food chain. The only POPs
that have been spread in French West Indies were technical grade
HCH, a mixture of a, b, and c isomers, mainly before 1970, and
chlordecone, intensively from 1973 to 1993; both were used to
control the banana root borer. Unlike HCH, chlordecone
undergoes no significant biotic or abiotic degradation in the
environment, and permanently polluted soils and waterways has
been and are still nowadays the major source of human
contamination in French West Indies, through the consumption
of contaminated foodstuffs [38]. The occupational profile of our
population study reflects that of the general male Guadeloupean
population aged from 45 to 70 years old. Among the 277 men
included in the study, only 29 are or have been workers on banana
farms and only 15 of these were occupationally exposed to
chlordecone during the period 1973–1993 (data not shown). This
unique situation provided us with an opportunity to study the
effects of three prevalent POPs with different endocrine modes of
action, at environmental exposure levels.
Our study population was randomly selected from among the
general population of Guadeloupe and we excluded any subjects
with abnormalities or medical conditions that may alter systemic
levels of steroid hormones. As a consequence, the values reported
may be considered as the normal range of values for the local male
population and for the age range investigated (45–70 years old)
[29].
Our findings provided some evidence of significant dose-
dependent effects. However, the association between exposure
and outcome differed between pollutants. DDE exposure levels
were negatively associated to DHT levels and positively associated
to LH concentration. Levels of PCB 153 were positively associated
to AD and E1 concentrations. By contrast, no association was
Organochlorine Pollutants and Steroid Hormones
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Table 1. Characteristics of the study population in terms of potential confounders and outcome variables.
Potential confounders
Age (years)a 58.3, 58.1 (45.1–69.9)
Education (%), high school, middle school, elementary school 9.3, 37.4, 53.3
BMI (kg/m2)a 24.7, 24.9 (17.9–29.8)
Waist-to-hip ratioa 0.90, 0.90 (0.72–1.29)
Current or past alcohol use (%) 84.8
Current or past smoking (%) 38.6
Total lipids (mg/dl)b 5.6 (3.7–8.6)
Season of blood sampling (%) summer, autumn, winter, spring 24.1, 29.0, 24.9, 22.0
Outcome variablesb, c
DHEA (nmol/l) 9.8 (4.3–19.8)
DHEAS (mmol/l) 2.8 (1.0–6.9)
AD (nmol/l) 4.0 (2.4–7.7)
ADIOL (nmol/l) 5.3 (1.5–12.4)
E1 (pmol/l) 152.2 (89.1–282.2)
E1S (nmol/l) 1.6 (0.6–4.5)
E2 (pmol/l) 110.1 (60.6–189.3)
T (nmol/l) 18.1 (9.4–31.4)
fT (nmol/l) 0.33 (0.16–0.61)
BT (nmol/l) 6.5 (3.4–10.6)
DHT (nmol/l) 1.9 (0.8–4.1)
SHBG (nmol/l) 35.2 (13.1–73.8)
FSH (IU/l) 6.6 (2.2–24.3)
LH (IU/l) 4.9 (2.0–12.0)
aValues are mean, median (minimum – maximum).
bValues are mean (5th–95th percentiles).
cBack-transformed values.
Abbreviations, DHEA: dehydroepiandrosterone; DHEAS: dehydroepiandrosterone sulfate; AD: androstenedione; ADIOL: androstenediol; E1: estrone; E1S: estrone sulfate;
E2: estradiol; T: testosterone; fT: free testosterone; BT: bioavailable; DHT: dihydrotestosterone; SHBG: sex hormone binding protein; FSH: follicle-stimulating hormone;
LH: luteinizing hormone.
doi:10.1371/journal.pone.0066460.t001
Table 2. Detection and concentrations (mg/l) of persistent organochlorine pollutants in serum samples of the study population.
Organochlorine
Detection
frequency Geometric mean Min Percentiles Max
(%) (mg/l) (mg/l) (mg/l) (mg/l)
10th 25th 50th 75th 90th
p,p9- DDT 34.9 - ,LD ,LD ,LD ,LD 0.06 0.17 1.71
p,p9- DDD 27.5 - ,LD ,LD ,LD ,LD 0.06 0.10 0.79
p,p9- DDE 96.9 1.77 ,LD 0.38 0.96 2.06 4.03 7.22 27.4
PCB 28 51.0 - ,LD ,LD ,LD 0.05 0.22 0.64 2.97
PCB 52 38.0 - ,LD ,LD ,LD ,LD 0.20 0.57 3.02
PCB 101 58.0 - ,LD ,LD ,LD ,LD 0.15 0.25 0.62
PCB 118 59.6 - ,LD ,LD ,LD ,LD 0.19 0.38 4.64
PCB 138 96.1 0.50 ,LD 0.16 0.33 0.53 0.94 1.45 4.12
PCB 153 98.5 0.75 ,LD 0.21 0.49 0.87 1.48 2.32 6.46
PCB 180 96.8 0.64 ,LD 0.24 0.42 0.67 1.08 1.66 5.52
a - HCH 39.6 - ,LD ,LD ,LD ,LD 0.09 0.15 1.20
b - HCH 41.6 - ,LD ,LD ,LD ,LD 0.08 0.12 0.69
c - HCH 38.0 - ,LD ,LD ,LD ,LD 0.08 0.14 1.12
Chlordecone 86.7 0.40 ,LD ,LD 0.20 0.45 0.95 1.74 44.1
Abbreviations, LD: limits of detection; DDT: dichlorodiphenyl trichloroethane; DDD: dichlorodiphenyl dichloroethane; DDE: dichlorodiphenyl dichloroethene; PCB:
polychlorinated biphenyl; HCH: hexachlorocyclohexane.
doi:10.1371/journal.pone.0066460.t002
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found between chlordecone exposure and any of the steroids,
binding proteins or gonadotrophins investigated.
Our findings are consistent with most previous studies,
regardless of the range of age and exposure levels considered,
showing an absence of association between the levels of DDE and
PCB 153 and those of T, E2, SHBG or FSH. However, some
conflicting results have been published, including lower testoster-
one levels with increasing PCB 153 levels in Native American men
aged 18 to 88 [17], lower E2 levels with increasing DDE levels in
Swedish fisherman aged 18 to 45 [15] and in Thai men aged 48 to
82 [13], and higher SHBG levels with increasing DDE and PCB
153 concentrations in Ukrainian men aged 19 to 45 years [14].
Haugen et al. [19] also reported an increase in SHBG
concentration with increasing PCB 153 levels, but not with
increasing DDE levels, in Norwegian men aged 19 to 40.
This study differs from previous studies in the field in several
ways. Major changes in blood steroid hormone levels occur during
adulthood, and studies covering broad age ranges, from early to
late adulthood may be inappropriate. By restricting our investi-
gation to the 45–69 year age range, we focused on a period in
which hormonal imbalance is known to play a key role in some
aging-related diseases. Other strengths of this study include the
simultaneous determination of serum concentrations of a large
number of steroid hormones, mostly by GC–MS. This sensitive
and specific method is currently considered the most accurate
approach to the determination of steroid hormones [26,27]. We
excluded obese subjects and those with acute or chronic
pathological conditions thought to have a strong impact on
hormone metabolism. We also collected extensive data for
adjustment on the basis of factors associated with changes in
blood steroid hormone levels and to reduce the bias of the
estimates.
Our cross-sectional study also presents several limitations. Given
the years during which DDT and PCBs were used worldwide, the
study population had been exposed to these chemicals or their
metabolites throughout much of their lifetimes. For chlordecone,
the exposure period began in 1973, at a median age of 30 years.
Single blood determinations to estimate exposure to these
contaminants may not adequately reflect past exposure. However,
unlike women, men are not subject to the mobilization of fat-
soluble pollutants during pregnancy or breastfeeding that can
significantly alter the pollutant load of the whole body. Any
previous weight loss or gain, particularly if large, may modify the
blood concentration of these pollutants, but we believe that this
factor had a weak influence overall in our free-chronic disease and
non-obese population study. Consequently, in adult healthy males,
and for chemicals with long half-lives in the body, single blood
determinations may be considered a satisfactory surrogate of past
exposure. Finally, we cannot exclude the possibility of confounding
with other undetermined chemicals, due to a lack of consideration
of interactions between chemicals or factors known to influence
blood steroid levels, such as diet and physical activity, or chance
findings.
Table 3. Regression coefficients (b) for association between serum pp9 DDE levels and the outcome variables.
Outcomes Crude Adjusted
b 95% CI (b) b 95% CI (b)
ln DHEA (nmol/l) 20.027 20.076 to 0.021 20.021a,b 20.067 to 0.026
ln DHEAS (mmol/l) 20.027 20.081 to 0.027 20.020a,c 20.073 to 0.033
ln AD (nmol/l) 0.014 20.021 to 0.050 0.010a,c–e,g 20.026 to 0.045
sqrt ADIOL (nmol/l) 20.017 20.080 to 0.047 20.010a–c,e 20.071 to 0.050
ln E2 (pmol/l) 0.022 20.008 to 0.052 0.018c 20.012 to 0.047
ln E1 (pmol/l) 0.016 20.018 to 0.050 0.004c,g 20.030 to 0.039
ln E1S (nmol/l) 0.052 20.009 to 0.112 0.037d,h 20.023 to 0.097
ln T (nmol/l) 20.010 20.043 to 0.023 20.003c,d 20.036 to 0.030
sqrt fT (nmol/l) 0.003 20.008 to 0.014 0.007a,g,i 20.003 to 0.017
sqrt BT (nmol/l) 20.003 20.044 to 0.037 0.013a,c,g 20.027 to 0.053
ln DHT (nmol/l) 20.062* 20.109 to 20.015 20.063* a,c–f 20.109 to 20.016
sqrt SHBG (nmol/l) 20.099 20.240 to 0.041 20.102a,d,f,i,j 20.230 to 0.026
ln LH (IU/l) 0.053* 0.001 to 0.106 0.057* a–d,h 0.005 to 0.109
ln FSH (IU/l) 0.023 20.042 to 0.088 0.001a,c,j 20.063 to 0.065
sqrt T/LH 20.066* 20.118 to–0.013 20.061*a–c,h 20.112 to 20.010
ln T/E2 20.032 20.065 to 0.0009 20.022c–e,g 20.054 to 0.010
a: age;
b: alcohol;
c: season of blood sampling;
d: BMI;
e: education;
f: chlordecone;
g: PCB-153;
h: smoking;
i: waist-to-hip-ratio;
j: blood total lipids.
*Statistically significant association because 95% CI (b) does not include zero.
doi:10.1371/journal.pone.0066460.t003
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We focused on steroid hormone levels in the general circulation,
but the results obtained may not be entirely representative of what
occurs in target tissues. Steroid hormones may act on tissues where
they are synthesized or be secreted into the blood and act remotely
on other target tissues [39,40]. Also, reduced T metabolites (DHT)
which are produced locally in target tissues may reenter the
general circulation. Endocrine-disrupting chemicals may exert
endocrine effects by a multitude of mechanisms that are not yet
fully understood and the pathways altering steroid hormone levels
may be unpredictable.
DDE has antiandrogenic effects in vivo, as assessed from
changes in the weights of androgen-responsive tissues [41]. Such
effects are likely to be mediated by inhibition of AR binding and/
or AR-dependent gene expression [23,42]. These properties
cannot directly explain the relationship between increased DDE
exposure and decreased serum DHT levels observed in our study
population. However, our findings provide a different type of
confirmation of the antiandrogenic properties of DDE. Interest-
ingly, Lo et al [43] have shown that DDE is able to inhibit 5a-
reductase in human prostate tissue homogenates. Because serum T
did not seem to be affected by DDE exposure and 5a-reductase is
involved in the conversion of T to DHT, it is plausible that
decreased serum DHT levels may be explained by 5a-reductase
inhibition. High levels of DDE also appeared to be associated with
high levels of LH. This finding may be related with the feedback
provided by circulating DHT, directly at the pituitary and
centrally at the level of the hypothalamus [44].
Many of the known endocrine activities of PCBs involve steroid
hormone signaling systems including estrogens, androgens, pro-
gestins and adrenal steroids [45]. Individual congeners may have
different, and in some cases even opposite effects. Some PCBs
have estrogenic activities, whereas others are antiestrogenic. The
most prevalent non dioxin-like PCBs (138, 153, and 180) have
been reported to be antiestrogenic in both reporter gene and
MCF-7 cell proliferation assays [46,47] and to decrease ER-
mediated activity in ER-CALUX bioassays (24). These studies led
to suggestions that these compounds might decrease the amounts
of E2 in the circulation [24,47]. However, other authors [48],
based on the observation that various environmentally relevant
PCB-hydroxylated metabolites are potent inhibitors of human
estrogen sulfotransferase, have suggested that PCBs may increase
E2 bioavailability in target tissues. Here, consistent with most
previous studies on adult men, we observed no change in blood E2
concentration as a function of non dioxin-like PCB levels. By
contrast, we found that PCB exposure was associated with high
levels of AD in the blood, an observation not previously reported
in humans. However, high levels of AD production have been
reported in the liver and testis of bulls chronically exposed to PCBs
[49]. There are two major pathways for the production of AD
from pregnenolone, one involving DHEA and the other,
progesterone. Because DHEA levels are not modified by PCBs
exposure, we can hypothesize that increased AD levels may have
its origin in any upstream step arising from the progesterone
pathway. The positive association between PCB 153 and E1 may
Table 4. Regression coefficients (b) for association between serum PCB-153 levels and the outcome variables.
Outcomes Crude Adjusted
b 95% CI (b) b 95% CI (b)
ln DHEA (nmol/l) 0.013 20.048 to 0.075 0.030a,b 20.029 to 0.088
ln DHEAS (mmol/l) 20.029 20.097 to 0.040 20.003a,c 20.072 to 0.065
ln AD (nmol/l) 0.045 20.0002 to 0.090 0.054*a,c–e 0.010 to 0.098
sqrt ADIOL (nmol/l) 0.022 20.059 to 0.102 0.032a–c,e 20.047 to 0.110
ln E2 (pmol/l) 0.018 20.020 to 0.056 0.025c 20.013 to 0.063
ln E1 (pmol/l) 0.047* 0.004 to 0.090 0.048*c 0.005 to 0.092
ln E1S (nmol/l) 0.030 20.047 to 0.108 0.037d,g 20.039 to 0.113
ln T (nmol/l) 20.015 20.057 to 0.027 20.006c,d 20.048 to 0.036
sqrt fT (nmol/l) 20.012 20.025 to 0.002 20.011a,f 20.023 to 0.002
sqrt BT (nmol/l) 20.046 20.098 to 0.005 20.029a,c 20.079 to 0.021
ln DHT (nmol/l) 20.051 20.112 to 0.009 20.031a,c–f 20.092 to 0.030
sqrt SHBG (nmol/l) 0.043 20.136 to 0.222 0.010a,d,f,h–j 20.072 to 0.272
ln LH (IU/l) 0.064 20.002 to 0.131 0.041a–d,g 20.029 to 0.110
ln FSH (IU/l) 0.071 20.011 to 0.153 0.051a–c,e 20.035 to 0.136
sqrt T/LH 20.071 20.138 to 20.005 20.037a–c, f–g 20.106 to 0.031
ln T/E2 20.032 20.074 to 0.009 20.036c–e 20.078 to 0.005
a: age;
b: alcohol;
c: season of blood sampling;
d: BMI;
e: education;
f: pp9-DDE;
g: smoking;
h: waist-to-hip-ratio;
i: blood total lipids;
j: chlordecone.
*Statistically significant association because 95% CI (b) does not include zero.
doi:10.1371/journal.pone.0066460.t004
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result from an increase in AD precursor levels, consistent with
mass action rather than an increase in aromatase activity.
Chlordecone binds ERa and ERb, acting as an agonist of ERa
and an antagonist of ERb [25,50]. In addition to its interaction
with nuclear ER, chlordecone may activate alternative estrogen
signaling pathways or other enzymes and receptors involved in
steroid homeostasis [51–54]. However, such modes of action did
not appear to affect circulating steroid levels in our population
study. Few studies have addressed the issue of the effect of
chlordecone exposure on the blood levels of steroid hormones or
gonadotrophins. Subchronic exposure of male rats to chlordecone
do not affect serum testosterone levels [55]. When primary rat
pituitary cell cultures were treated with chlordecone, basal
secretion of FSH and LH were not altered [56]. To our
knowledge, there have been no studies on humans to investigate
the effects of chlordecone on circulating levels of steroid hormones,
binding proteins or gonadotropins. Here, as in a preliminary study
we carried out in 100 healthy male subje[ts aged 20 to 50 years
[57], we found no significant association between chlordecone
exposure at environmental levels and the concentrations of
steroids, binding proteins or gonadotrophins investigated.
The ethnic origin of study populations must also be taken into
account. Most previous studies were carried out on men of
European descent, whereas our study population was of African
descent. We recently reported differences in the concentrations of
certain steroids in the blood (particularly AD and E1) between our
study population and healthy European men of similar age [29].
This may be explained by different levels of transcription or allele
frequency of polymorphisms of steroid hormone related genes
[58]. Consequently, we cannot exclude that EDCs effects on
steroid hormone levels may be at least partially ethnically sensitive.
In summary, in this cross-sectional study performed in middle-
age men, we found that the pattern of endocrine response,
estimated by blood levels of steroid hormones, to long-term
exposure of POPs with endocrine activity varies depending on the
pollutant studied. Such differential pattern could be related to the
different modes of action that are usually attributed to them. It
remains unclear whether such changes in circulating steroid
hormone levels are predictive of the subsequent occurrence of
disease.
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Table 5. Regression coefficients (b) for association between serum chlordecone levels and the outcomes variables.
Outcomes Crude Adjusted
b 95% CI (b) b 95% CI (b)
ln DHEA (nmol/l) 0.001 20.044 to 0.040 20.005a,b 20.053 to 0.042
ln DHEAS (mmol/l) 20.006 20.058 to 0.046 20.016a–d 20.069 to 0.036
ln AD (nmol/l) 0.020 20.014 to 0.054 0.013b–d,f,g 20.021 to 0.048
sqrt ADIOL (nmol/l) 0.048 20.013 to 0.108 0.041c,d,g 20.022 to 0.105
ln E2 (pmol/l) 0.003 20.025 to 0.032 20.011a,c–e,g,h 20.018 to 0.041
ln E1 (pmol/l) 0.007 20.026 to 0.039 0.016b–d,h 20.019 to 0.050
ln E1S (nmol/l) 0.014 20.044 to 0.072 20.014 20.044 to 0.072
ln T (nmol/l) 0.014 20.018 to 0.046 0.009a,d,e 20.025 to 0.042
sqrt fT (nmol/l) 20.004 20.014 to 0.007 20.004c,g,h,j 20.005 to 0.013
sqrt BT (nmol/l) 0.0004 20.040 to 0.041 20.001d,i,j 20.042 to 0.039
ln DHT (nmol/l) 0.030 20.016 to 0.075 0.027a,b,d,e 20.029 to 0.061
sqrt SHBG (nmol/l) 0.067 20.064 to 0.198 0.061b,d 20.074 to 0.196
ln LH (IU/l) 20.022 20.071 to 0.025 20.019d 20.071 to 0.031
ln FSH (IU/l) 20.023 20.073 to 0.026 20.018c 20.082 to 0.045
sqrt T/LH 0.043 20.020 to 0.106 0.059c,d,i 20.003 to 0.123
ln T/E2 0.012 20.020 to 0.044 0.007d,g 20.025 to 0.040
a: education;
b: smoking;
c: age;
d: season of blood sampling;
e: BMI;
f: blood total lipids;
g: PCB-153;
h: pp9-DDE;
i: alcohol;
j: waist-to-hip-ratio.
doi:10.1371/journal.pone.0066460.t005
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